Go to content
UR Home

The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

URN to cite this document:
urn:nbn:de:bvb:355-epub-361537
Rosenow, F. ; Schade-Brittinger, C. ; Burchardi, N. ; Arnold, Stephan ; LaLiMo Study Group,
[img]
Preview
License: Allianz- bzw. Nationallizenz
PDF - Published Version
(176kB)
Date of publication of this fulltext: 05 Sep 2017 13:49


Abstract

Background: Of the newer antiepileptic drugs, lamotrigine (LTG) and levetiracetam (LEV) are popular first choice drugs for epilepsy. The authors compared these drugs with regard to their efficacy and tolerability in the initial monotherapy for epilepsy. Methods: A randomised, open-label, controlled, parallel group, multicenter trial was conducted to test the superiority of the LEV arm over the ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons